Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses
Author(s) -
Ruofan Wang,
Camille R. Simoneau,
Jessie Kulsuptrakul,
Mehdi Bouhaddou,
Katherine Travisano,
Jennifer M. Hayashi,
Jared Carlson-Stevermer,
James Zengel,
Christopher M. Richards,
Parinaz Fozouni,
Jennifer Oki,
Lauren Rodriguez,
Bastian Joehnk,
Keith Walcott,
Kevin Holden,
Anita Sil,
Jan E. Carette,
Nevan J. Krogan,
Mélanie Ott,
Andreas S. Puschnik
Publication year - 2020
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2020.12.004
Subject(s) - biology , coronaviridae , coronavirus , virology , betacoronavirus , mouse hepatitis virus , viral replication , phosphatidylinositol , virus , kinase , genetics , covid-19 , disease , infectious disease (medical specialty) , pathology , medicine
The Coronaviridae are a family of viruses that cause disease in humans ranging from mild respiratory infection to potentially lethal acute respiratory distress syndrome. Finding host factors common to multiple coronaviruses could facilitate the development of therapies to combat current and future coronavirus pandemics. Here, we conducted genome-wide CRISPR screens in cells infected by SARS-CoV-2 as well as two seasonally circulating common cold coronaviruses, OC43 and 229E. This approach correctly identified the distinct viral entry factors ACE2 (for SARS-CoV-2), aminopeptidase N (for 229E), and glycosaminoglycans (for OC43). Additionally, we identified phosphatidylinositol phosphate biosynthesis and cholesterol homeostasis as critical host pathways supporting infection by all three coronaviruses. By contrast, the lysosomal protein TMEM106B appeared unique to SARS-CoV-2 infection. Pharmacological inhibition of phosphatidylinositol kinases and cholesterol homeostasis reduced replication of all three coronaviruses. These findings offer important insights for the understanding of the coronavirus life cycle and the development of host-directed therapies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom